Home/Filings/4/0001209191-20-064645
4//SEC Filing

Daly Timothy 4

Accession 0001209191-20-064645

CIK 0001636651other

Filed

Dec 20, 7:00 PM ET

Accepted

Dec 21, 4:34 PM ET

Size

5.4 KB

Accession

0001209191-20-064645

Insider Transaction Report

Form 4
Period: 2020-12-17
Daly Timothy
VP, Finance & Corp. Controller
Transactions
  • Award

    Stock Option (Right to Buy)

    2020-12-17+125,000125,000 total
    Exercise: $2.82Exp: 2030-12-16Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the Stock Option will vest and become exercisable on December 17, 2021 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.

Issuer

Ovid Therapeutics Inc.

CIK 0001636651

Entity typeother

Related Parties

1
  • filerCIK 0001535896

Filing Metadata

Form type
4
Filed
Dec 20, 7:00 PM ET
Accepted
Dec 21, 4:34 PM ET
Size
5.4 KB